IDL Biotech AB operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IDL Biotech AB with three other
pharmaceutical manufacturers in Europe:
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS
sales of 31.81 million Turkish Liras [US$8.65 million]
(8.20 million Euro [US$9.67 million]
based in Germany
(4.20 million Euro [US$4.95 million]
of which 53%
was Product sales (own and third party)).
IDL Biotech AB reported sales of SEK 33.49 million (US$4.11 million)
December of 2016.
increase of 17.5%
versus 2015, when the company's sales were SEK 28.52 million.
Sales at IDL Biotech AB have increased during each of the previous five years
(and since 2011, sales have increased a total of 130%).